Page last updated: 2024-11-05

trihexyphenidyl and Cerebromalacia

trihexyphenidyl has been researched along with Cerebromalacia in 2 studies

Trihexyphenidyl: One of the centrally acting MUSCARINIC ANTAGONISTS used for treatment of PARKINSONIAN DISORDERS and drug-induced extrapyramidal movement disorders and as an antispasmodic.

Research Excerpts

ExcerptRelevanceReference
"Treatment with trihexyphenidyl resulted in significant improvement of the dystonia and scoliosis."1.28Posttraumatic segmental axial dystonia. ( Jabbari, B; Paul, J; Scherokman, B; Van Dam, B, 1992)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bamford, A1
Crowe, BH1
Hacohen, Y1
Lin, JP1
Clarke, A1
Tudor-Williams, G1
Sancho-Shimizu, V1
Vincent, A1
Lim, M1
Pullaperuma, SP1
Jabbari, B1
Paul, J1
Scherokman, B1
Van Dam, B1

Other Studies

2 other studies available for trihexyphenidyl and Cerebromalacia

ArticleYear
Pediatric Herpes Simplex Virus Encephalitis Complicated by N-Methyl-D-aspartate Receptor Antibody Encephalitis.
    Journal of the Pediatric Infectious Diseases Society, 2015, Volume: 4, Issue:2

    Topics: Acyclovir; Anti-N-Methyl-D-Aspartate Receptor Encephalitis; Antiviral Agents; Autoantibodies; Clonid

2015
Posttraumatic segmental axial dystonia.
    Movement disorders : official journal of the Movement Disorder Society, 1992, Volume: 7, Issue:1

    Topics: Accidental Falls; Adult; Athletic Injuries; Dystonia; Encephalomalacia; Follow-Up Studies; Head Inju

1992